LivingGLP1
crossover randomized trial

S003438

Design

Randomized
Start year
2021
Treatment
0.03 weeks, follow-up 0.14 weeks
Countries
Netherlands (1 sites)
Sponsor
(non industry)
Eligibility
men of European descent aged 40 to 75; HbA1c 6.0 to 10.0 percent; eGFR above 60; metformin with or without sulfonylurea

Conduct and analysis

Blinding
double blind
Sequence generation
computer
Allocation concealment
not reported
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
Missing data

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Intravenous sodium load
Intravenous sodium load
metformin with or without sulfonylurea; lifestyle: standard11
A2Placebo
Oral sodium load with placebo
oral sodium load 150 mmol in 300 mL broth; lifestyle: standard11
A3exenatide
Oral sodium load with exenatide
oral sodium load 150 mmol in 300 mL broth; lifestyle: standard11

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticIntravenous sodium load
A1
Placebo
A2
Oral sodium load with exenatide
A3
Whole trial
ALL
agemean (years)60
agesd (years)5
bmimean (kg/m2)31.9
bmisd (kg/m2)3.9
diabetes durationmean (years)10.6
diabetes durationsd (years)6.3
egfrmean (mL/min/1.73 m2)89
egfrsd (mL/min/1.73 m2)5
hba1cmean (percent)7.5
hba1csd (percent)0.9
metformin usen11
metformin usepercent100
other normoalbuminurian11
other normoalbuminuriapercent100
other sulfonylurea usen2
other sulfonylurea usepercent18
sbpmean (mmHg)127
sbpsd (mmHg)22
weightmean (kg)104.1
weightsd (kg)12.6

Results

6 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (6 lines; O05)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
0.14A1final132 mmHg14not stated; other; R0029290:Table 3
0.14A1final113 mmHg13not stated; other; R0029290:Table 3
0.14A2final128 mmHg16not stated; other; R0029290:Table 3
0.14A2final111 mmHg16not stated; other; R0029290:Table 3
0.14A3final130 mmHg12not stated; other; R0029290:Table 3
0.14A3final115 mmHg13not stated; other; R0029290:Table 3